Analyst firms · Raymond James · RVMD
Raymond James RVMD price target and rating history
Revolution Medicines Inc. (RVMD) · Health Care
Raymond James rates Revolution Medicines Inc. (RVMD) Strong Buy with a $72 price target, as of its latest action on Sep 12, 2025. It has published 3 rating actions on RVMD since November 2023, including 1 upgrade and 0 downgrades. Across 5 firms with a RVMD price target in the last 12 months, the median target is $179.
- Current rating
- Strong Buy
- Price target
- $72
- Median target, all firms
- $179
- Actions on RVMD
- 3
Raymond James price target on RVMD
Every Raymond James rating on RVMD
- Sep 12, 2025
- Apr 10, 2024
- Nov 16, 2023
How other firms rate RVMD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Oct 16, 2026 | |
| Goldman Sachs | Buy | $267 | Sep 24, 2026 |
| Morgan Stanley | Overweight | $255 | Sep 10, 2026 |
| Bernstein | Mkt Perform | $151 | May 22, 2026 |
| Truist Securities | Buy | $179 | May 18, 2026 |
| Jefferies | Buy | Mar 16, 2026 | |
| UBS | Buy | $145 | Feb 27, 2026 |
Questions about Raymond James and RVMD
- What is Raymond James's price target for RVMD?
- Raymond James's latest stated price target for Revolution Medicines Inc. (RVMD) is $72, from its action on Sep 12, 2025.
- What is Raymond James's rating on RVMD?
- Raymond James rates RVMD Strong Buy, a bullish rating, as of Sep 12, 2025.
- When did Raymond James last change its view on RVMD?
- On Sep 12, 2025, Raymond James resumes coverage at Strong Buy, price target $72.
- How does Raymond James's RVMD target compare with other analysts?
- Across 5 firms with a RVMD price target in the last 12 months, the median target is $179.
More RVMD rating histories
All Raymond James ratingsRVMD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.